Cargando…

Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer

BACKGROUND: Testicular cancer survivors often have impaired gonadal function possibly related to chemotherapy. Platinum is a heavy metal that can be detected at low levels in serum many years after treatment, it is not known whether platinum also persists in semen and if platinum persistence in seme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malone, Eoghan R., Lewin, Jeremy, Li, Xuan, Zhang, Wen‐Jiang, Lau, Susan, Jarvi, Keith, Hamilton, Robert J., Hansen, Aaron R., Chen, Eric X., Bedard, Philippe L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817086/ https://www.ncbi.nlm.nih.gov/pubmed/34918879 http://dx.doi.org/10.1002/cam4.4480

Ejemplares similares

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
por: Albany, Costantine, et al.
Publicado: (2020)

Quality of patient‐reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic review
por: Malone, Eoghan, et al.
Publicado: (2021)

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study
por: Sayal, Karen, et al.
Publicado: (2015)

Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors
por: Funt, Samuel A., et al.
Publicado: (2021)

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors
por: Gariscsak, Peter J., et al.
Publicado: (2022)

Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
por: Haugnes, Hege S., et al.
Publicado: (2021)

Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell Tumors
por: Lewin, Jeremy, et al.
Publicado: (2018)

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
por: Mego, Michal, et al.
Publicado: (2021)

Immature germ cells in semen – correlation with total sperm count and sperm motility
por: Patil, Priya S., et al.
Publicado: (2013)

Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
por: Tran, Ben, et al.
Publicado: (2019)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
por: Hastings, Jordan F, et al.
Publicado: (2020)

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
por: Jay, Alexander P.M., et al.
Publicado: (2021)

Employment status and occupational level of adult survivors of childhood cancer in Great Britain: The British childhood cancer survivor study
por: Frobisher, Clare, et al.
Publicado: (2017)

‘Semen Contains Vitality and Heredity, Not Germs’: Seminal Discourse in the AIDS Era
por: Khan, Sharful Islam, et al.
Publicado: (2006)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin
por: Hamilton, Gerhard
Publicado: (2014)

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma
por: Gonzalez Rajal, Alvaro, et al.
Publicado: (2021)

Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort
por: Malburg, Carly M., et al.
Publicado: (2020)

Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor
por: Chang, Yuting, et al.
Publicado: (2019)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
por: Diaz Osterman, Carlos J, et al.
Publicado: (2019)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
por: Zhao, Chong, et al.
Publicado: (2016)

The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study
por: Bonet, Catalina, et al.
Publicado: (2023)

Bioinformatic profiling identifies a platinum‐resistant–related risk signature for ovarian cancer
por: Wu, Ce, et al.
Publicado: (2019)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Efficacy and safety of low‐dose apatinib in ovarian cancer patients with platinum‐resistance or platinum‐refractoriness: A single‐center retrospective study
por: Chen, Wei, et al.
Publicado: (2020)

Erectile Dysfunction in Germ Cell Tumor Survivors
por: Okada, Koichi, et al.
Publicado: (2021)

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway
por: Yang, Ying, et al.
Publicado: (2021)

FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
por: Xiong, Xifeng, et al.
Publicado: (2022)

Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
por: Takekuma, Munetaka, et al.
Publicado: (2015)

LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2018)

SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma
por: Brown, Austin L, et al.
Publicado: (2015)

The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model
por: Wertman, Jaime N, et al.
Publicado: (2020)

Risk factors associated with suicide in adolescents and young adults (AYA) with cancer
por: Heynemann, Sarah, et al.
Publicado: (2021)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Impact of immigration status on health behaviors and perceptions in cancer survivors
por: Liu, Sophia Y., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u5v2jc47btle8jcd9ecrtg0ur9